Science Explorer Interactive view Map
Company · Boston · United States

Ginkgo Bioworks, Inc. (United States)

ginkgo.bioROR OpenAlex
Research works
46
▲ 233% vs 2013–17
Citations
969
21.2 per fractional work
Top-10% rate
32.4%
record average 16.5%
Open access
71%
world 28%

Not ranked overall: Ginkgo Bioworks, Inc. (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.96× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.08× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 1.00× its world share, 0 worksImmunology and Micro…Neuroscience: 0.55× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.35× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.68× its world share, 0 worksChemistryComputer Science: 0.23× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.27× its world share, 0 worksEarth and Planetary …Engineering: 0.52× its world share, 2 worksEngineeringEnvironmental Science: 0.59× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.32× its world share, 0 worksMaterials ScienceMathematics: 2.27× its world share, 1 worksMathematicsPhysics and Astronomy: 0.14× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 1.88× its world share, 8 worksMedicineVeterinary: 3.93× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 1.21× its world share, 1 worksBusiness, Management…Decision Sciences: 1.45× its world share, 0 worksDecision SciencesSocial Sciences: 0.11× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.1×. Every wedge is a field page.

Which keywords describe research at Ginkgo Bioworks, Inc. (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: CAR T Cells, Chimeric Antigen Receptor, SARS-CoV-2, COVID-19, Biosensors, Biodiversity, Vaccine and One Health.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. CAR T Cells2▲ 131×1 topic
  2. COVID-192▲ 7.0×6 topics
  3. Chimeric Antigen Receptor2▲ 131×1 topic
  4. SARS-CoV-22▲ 29×3 topics
  5. Biodiversity1▲ 8.8×2 topics
  6. Biosensors1▲ 13×3 topics
  7. Globalization1▲ 2.9×2 topics
  8. One Health1▲ 174×1 topic
  9. Vaccine1▲ 14×2 topics
  10. Zoonotic Diseases1▲ 174×1 topic
  11. Diagnostics1▲ 63×1 topic
  12. Innovation1▲ 5.2×3 topics
  13. Pandemic1▲ 4.7×3 topics
  14. wastewater surveillance1▲ 170×1 topic
  15. Pathogenesis1▲ 9.8×3 topics

Which research topics does Ginkgo Bioworks, Inc. (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Zoonotic diseases and public health, SARS-CoV-2 detection and testing and SARS-CoV-2 and COVID-19 Research.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksZoonotic diseases and public health: 1 fractional worksSARS-CoV-2 detection and…1SARS-CoV-2 detection and testing: 1 fractional worksSARS-CoV-2 and COVID-19 …1SARS-CoV-2 and COVID-19 Research: 1 fractional worksCRISPR and Genetic Engineering: 1 fractional worksMicrobial Metabolic Engineering and Bioproduction: 1 fractional worksCOVID-19 epidemiological…1COVID-19 epidemiological studies: 1 fractional worksBacillus and Francisella bacterial research: 1 fractional worksPrivate Equity and Venture Capital: 0 fractional worksGout, Hyperuricemia, Uric Acid: 0 fractional works
OncologyPublic Health, Environmental and Occupational HealthInfectious DiseasesMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Zoonotic diseases and public health Public Health, Environmental and Occupational Health 1 works
  3. 3 SARS-CoV-2 detection and testing Infectious Diseases 1 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  5. 5 CRISPR and Genetic Engineering Molecular Biology 1 works
  6. 6 Microbial Metabolic Engineering and Bioproduction Molecular Biology 1 works
  7. 7 COVID-19 epidemiological studies Modeling and Simulation 1 works
  8. 8 Bacillus and Francisella bacterial research Molecular Biology 1 works
  9. 9 Private Equity and Venture Capital Accounting 0 works
  10. 10 Gout, Hyperuricemia, Uric Acid Nephrology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available70.9%not open29.1%

World: 28% of research is openly available.

with international co-authors40.8%domestic only59.2%

World: 19% is written across borders.

How has Ginkgo Bioworks, Inc. (United States)'s research output changed?

Output in 2018–2022 was 233% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.